Latest

psychopharmacology

·May 2, 2023·5 min read

Decoding the Molecular Mechanisms of Psilocybin Mushrooms’ Hallucinogenic Effects

A new study adds to the growing body of evidence suggesting psilocybin, a hallucinogenic compound found in certain mushroom species, could potentially revolutionize the treatment of depression and substance addiction. Researchers focused on the molecular interactions of psilocybin in the brain. The findings may help with designing new drugs that can treat a range of mental health disorders.

Featured Neuroscience Psychology

·May 2, 2023·6 min read

Harnessing Psilocybin to Treat PTSD

Psilocybin, the active ingredient in magic mushrooms, can restore fear extinction and help treat post-traumatic stress disorder (PTSD). The study found that psilocybin promotes the growth of new neurons and synapses in the hippocampus, a brain region involved in memory formation, and was found to reverse the decline in proteins associated with neuroplasticity and fear extinction. The findings provide a promising potential for using psilocybin in the treatment of PTSD.

Featured Neuroscience Psychology

·April 28, 2023·5 min read

Insomnia Drug Belsomra May Help Treat Opioid Addiction

A preclinical study found that suvorexant (Belsomra), an insomnia drug, could be a potential treatment for opioid use disorder (OUD) in rats. If the results are replicated in humans, the drug could offer a promising treatment for the millions of people with OUD and reduce drug intake and block relapse.

Featured Neuroscience Psychology

·April 27, 2023·5 min read

Experts Call for Creative Regulations and Collaboration for Psychedelics in Mental Health Treatment

Experts in bioethics, law and policy from top universities in the US call for creative and collaborative policies to regulate the use and oversight of psychedelics for treating conditions like depression and post-traumatic stress disorder. In a paper published in the journal Science, the authors propose solutions to regulatory challenges in anticipation of FDA approval of psychedelics for medical use, while stressing the need for a strong evidence base for efficacy and safety.

Featured Neuroscience Psychology

·April 25, 2023·3 min read

Enlightening Study Explores the Neurobiology of Psychedelics

Researchers studied the brain activity of healthy participants under the influence of nitrous oxide, comparing it to data from studies with ketamine and LSD to see whether the neurobiology of the psychedelic experience was similar. They found that the patterns of activity associated with the different substances overlapped, indicating common underlying biology, which could inform future research on the therapeutic use of psychedelics.

This shows DNA and the outline of a person

Featured Genetics Neuroscience Psychology

·April 7, 2023·6 min read

New Genetic Finding Provides Clue for Personalizing Depression Treatment

The NPAS4 gene may play a critical role in linking long-term stress to depression and depressive behaviors. The findings may lead to new, targeted treatments for depression as a result of chronic stress.

Featured Neuroscience Psychology

·April 5, 2023·3 min read

How Prozac Increases Brain Plasticity

Fluoxetine (Prozac), a common antidepressant, was found to enhance the erasure of learned fear responses and facilitate spatial pattern learning in mice. The study also found the TrkB receptor in PV+ interneurons plays a crucial role in these effects, which may offer new possibilities for the development of psychiatric treatments targeting brain plasticity.

Featured Neuroscience Psychology

·March 31, 2023·6 min read

The Cognitive Benefits of Psychedelics

Researchers are investigating the benefits of psychedelics on cognition from memory malleability to cognitive creativity.

Featured Neuroscience Psychology

·March 28, 2023·3 min read

The Drugs Don’t Work: Meditation and Training Are Better at Sparking Creativity

Despite the common myth, alcohol and narcotics are the least effective means to spark creativity, researchers report. Instead, complex training, meditation, and cultural exposure add a boost to your creative flow.

Featured Neuroscience Psychology

·March 26, 2023·5 min read

Antidepressant Withdrawal Should Be Taken Seriously

It can take nine months or more for people who have used antidepressants for a long term to find relief from withdrawal symptoms. Researchers address the common symptoms of antidepressant withdrawal and steps to take to help improve symptoms.

Featured Neuroscience Psychology

·March 23, 2023·4 min read

Use of Melatonin Linked to Decreased Self-Harm in Young People

Melatonin reduces self-harm in young people with depression and anxiety. The effects were more pronounced in females with anxiety and depression.

Featured Neuroscience Psychology

·March 20, 2023·5 min read

How DMT Psychedelic Alters Perception of Reality

The psychedelic compound DMT (Dimethyltryptamine) increases connectivity across the brain, allowing for greater communication between different areas and networks. The brain changes are most prominent in brain areas linked to higher functioning, such as imagination.

1 2 3 4 5 … 32

psychopharmacology

Decoding the Molecular Mechanisms of Psilocybin Mushrooms’ Hallucinogenic Effects

Harnessing Psilocybin to Treat PTSD

Insomnia Drug Belsomra May Help Treat Opioid Addiction

Experts Call for Creative Regulations and Collaboration for Psychedelics in Mental Health Treatment

Enlightening Study Explores the Neurobiology of Psychedelics

New Genetic Finding Provides Clue for Personalizing Depression Treatment

How Prozac Increases Brain Plasticity

The Cognitive Benefits of Psychedelics

The Drugs Don’t Work: Meditation and Training Are Better at Sparking Creativity

Antidepressant Withdrawal Should Be Taken Seriously

Use of Melatonin Linked to Decreased Self-Harm in Young People

How DMT Psychedelic Alters Perception of Reality

Blood Biomarkers Highlight Immune Disruption in Long-COVID

Congress Tweets: Belief-Speak, Facts, and Trustworthiness Decoded

Brain Signals Decipher Memory Variations

Subscribe